Rankings
▼
Calendar
ESPR FY 2015 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ESPR
Esperion Therapeutics, Inc.
$512M
FY 2015 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
-$236,000
Operating Income
-$50M
Net Income
-$50M
EPS (Diluted)
$-2.26
Cash Flow
Operating Cash Flow
-$38M
Free Cash Flow
-$38M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$296M
Total Liabilities
$8M
Stockholders' Equity
$287M
Cash & Equivalents
$77M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$236,000
$0
—
Operating Income
-$50M
-$36M
-38.1%
Net Income
-$50M
-$36M
-36.9%
← FY 2014
All Quarters
Q4 2015 →